Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation
about
Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Stroke and Bleeding Risks in N ...... opathy and Atrial Fibrillation
@en
type
label
Stroke and Bleeding Risks in N ...... opathy and Atrial Fibrillation
@en
prefLabel
Stroke and Bleeding Risks in N ...... opathy and Atrial Fibrillation
@en
P2093
P1476
Stroke and Bleeding Risks in N ...... opathy and Atrial Fibrillation
@en
P2093
Bernard J Gersh
Nilay D Shah
Peter A Noseworthy
P304
P356
10.1016/J.JACC.2016.04.026
P50
P577
2016-06-01T00:00:00Z